图书简介 馆藏图书馆

Chapter 1. Relevant Anatomy and Physiology; 1.1 INFRANUCLEAR OCULAR MOTOR ANATOMY; 1.1.1 Extraocular Muscles; 1.1.2 Extraocular Muscle Pulleys; 1.1.3 Orbital Tissues; 1.2 SUPRANUCLEAR OCULAR MOTOR ANATOMY; 1.2.1 Frontal Eye Fields; 1.2.2 Superior Colliculus; 1.2.3 Brainstem Nuclei; 1.2.4 Vestibular Nuclei; 1.2.5 Cerebellum; 1.3 AFFERENT SYSTEM; 1.3.1 Retina/Optic Nerve; 1.3.2 Optic Nerve; 1.3.3 Lateral Geniculate; 1.3.4 Geniculostriate; 1.3.5 Association Cortex; 1.3.6 Ocular Motor Proprioception; 1.4 EFFERENT SYSTEM; 1.4.1 Smooth Pursuit System; 1.4.2 Saccadic System; 1.4.3 Vergence System; 1.4.4 Vestibuloocular System; Chapter 2. Infantile Nystagmus Syndrome; 2.1 CHARACTERISTICS OF INS; 2.1.1 History and Background; 3.1.1.1 Ancient Descriptions and Theories; 3.1.1.2 Connection to Fixation Attempt; 3.1.1.3 Modern Physiological Investigation; 2.1.2 Waveforms, Models, and Mechanisms; 3.1.2.1 Waveform Types; 3.1.2.2 Braking and Foveating Saccades; 3.1.2.3 The Foveation Period; 3.1.2.4 Foveation Accuracy; 3.1.2.5 Target Acquisition Time; 3.1.2.6 Smooth Pursuit; 2.1.3 The Static Neutral Zone/Region; 3.1.3.1 Latent Component; 2.1.4 The Dynamic Neutral Zone/Region; 3.1.4.1 Asymmetric, (a)Periodic Alternation; 3.1.4.2 Optokinetic, Pursuit and Vestibuloocular Responses; 2.1.5 The Null Angle/Zone/Region; 2.1.6 The Convergence Null; 2.1.7 The Saccadic Response; 2.1.8 Static and Dynamic Head Posturing; 2.1.9 Foveation and Visual Acuity (High Spatial Frequency Vision); 2.1.9.1. The eXpanded Nystagmus Acuity Function (NAFX); 2.1.9.1.1 NAFX vs. Gaze Angle; 2.1.9.1.2 LFD and TID; 2.1.10 Oscillopsia Suppression; 2.1.10.1 Foveation Dynamics; 2.1.10.2 Temporal Sampling; 2.1.10.3 Efference Copy; 2.1.11 Afferent Stimulation; 2.1.11.1 Cutaneous Trigeminal Stimulation; 2.1.11.2 Deep Muscle Stimulation; 2.1.11.3 Contact Lenses; 2.1.11.4 Biofeedback; 2.1.12 Canine Nystagmus (Achiasmatic Belgian Sheepdog); 2.1.12.1 See-Saw; 2.1.12.2 Pendular; 2.1.12.3 Tenotomy & Reattachment Procedure; 2.1.13 Canine Model of INS with RPE65 Retinal Degeneration (Briard); 2.2 ETIOLOGY OF INS; 2.2.1 Familial (Gene Defect); 2.2.2 Developmental Disturbance Of Ocular Motor System with Associated Sensory System Deficit.; 2.2.2.1 Albinism; 2.2.2.2 Achiasma; 2.2.2.3 Infantile Strabismus; 2.2.2.4 Non-vectorial Visual Sensory Deficits; 2.2.3 The Direct Cause(s) of INS with or without Sensory/Genetic Deficits; 2.2.3.1 Loss of Smooth-Pursuit Damping; 2.2.3.2 Tonic Vestibular-Optokinetic Imbalance; 2.3 VISUAL FUNCTION DEFICITS AND MEASUREMENTS OF INS; 2.3.1 Static Deficits; 2.3.1.1 The eXpanded Nystagmus Acuity Function and Longest Foveation; Domain Measures; 2.3.2 Dynamic Deficits; 2.3.2.1 Target Acquisition Time (Stationary Targets); 2.3.2.2 Target Acquisition Time (Moving Targets); 2.3.3 Clinical; 2.3.3.1 Visual Acuity at Different Gaze Angles; 2.4 TREATMENTS OF INS; 2.4.1 Goals; 2.4.2 Non-Surgical; 2.4.2.1 Prisms; 2.4.2.2 Contact Lenses; 2.4.2.3 Drugs; 2.4.2.4 Biofeedback; 2.4.2.5 Gene-Transfer Therapy; 2.4.3 Surgical; 2.4.3.1 Four-Muscle Resection & Recession Procedure (Operation 1); (aka Kestenbaum, Anderson-Kestenbaum, or Anderson+Goto); 2.4.3.2 Two-Muscle Recession Procedure (Operation 1A) (aka Anderson); 2.4.3.3 Bilateral Medial Rectus Recession Procedure (Operation 8); 2.4.3.4 Tenotomy & Reattachment Procedure (Operation 6); Chapter 3. Fusion Maldevelopment Nystagmus Syndrome; 3.1 CHARACTERISTICS OF FMNS; 3.1.1 Waveforms, Models, and Mechanisms; 3.1.1.1 Types (FMNS plus Nucleus of the Optic Tract); 3.1.1.2 The Fixating Eye; 3.1.1.3 Target Foveation and Dual-Mode Fast Phases; 3.1.1.4 Foveation Accuracy; 3.1.2 Variation with Gaze Angle; 3.1.3 Head Position; 3.1.4 Foveation, NAFX, and Acuity; 3.1.5 Efference Copy, Foveation, and Oscillopsia Suppression; 3.2 TREATMENTS OF FMNS; 3.2.1. Fixation Preference; 3.2.2. Alexander’s Law; 3.2.3. Eye Muscle Surgery; Chapter 4. Other Types of Nystagmus of Infancy; 4.1 NYSTAGMUS BLOCKAGE SYNDROME; 4.1.1 Characteristics of NBS; 4.1.1.1 Multiple Types of Nystagmus; 4.1.1.2 Waveforms and Mechanisms; 4.1.1.2.1 Target Foveation; 4.1.1.2.2 Foveation Accuracy; 4.1.1.3 Purposive Esotropia; 4.1.1.4 Head Position; 4.1.1.5 Blockage Syndrome Types I and II; 4.1.1.6 Foveation, NAFX, and Acuity; 4.1.1.7 Efference Copy, Foveation, and Oscillopsia Suppression; 4.1.2 Treatments of NBS; 4.1.2.1. Fixation Preference; 4.1.2.2. Alexander’s Law; 4.1.2.3. Surgical; 4.1.2.3.1. Fixating Eye; 4.2 SPASMUS NUTANS SYNDROME; 4.2.1 Characteristics of SNS; 4.2.1.1 Waveforms and Mechanisms; 4.2.1.2 Variable Interocular Phase; 4.2.1.3 Head Nodding; 4.2.2 Treatment of SNS; Chapter 5. Differential Diagnosis of Nystagmus In Infancy and Childhood; 5.1 NYSTAGMUS WITHOUT ASSOCIATED NEUROLOGICAL DISEASE-BENIGN; 5.1.1. Infantile Nystagmus Syndrome; 5.1.1.1 Association with Strabismus; 5.1.1.2 Clinical Signs and Symptoms; 5.1.1.3 Differential Diagnosis; 5.1.1.4 Reverse-Cover and Gaze-Angle Cover Tests; 5.1.2 Fusion Maldevelopment Nystagmus Syndrome; 5.1.2.1 Association with Strabismus; 5.1.2.2 Clinical Signs and Symptoms; 5.1.2.3 Differential Diagnosis; 5.1.2.4 Alternate-Cover and Gaze-Angle Cover Tests; 5.1.3 Nystagmus Blockage Syndrome; 5.1.3.1 Association with Strabismus; 5.1.3.2 Clinical Signs and Symptoms; 5.1.3.3 Differential Diagnosis; 5.1.4 Spasmus Nutans Syndrome; 5.1.4.1 Association with Strabismus; 5.1.4.2 Clinical Signs and Symptoms; 5.1.4.3 Differential Diagnosis; 5.1.5 Nystagmus and Strabismus; 5.2 NYSTAGMUS WITH ASSOCIATED NEUROLOGICAL DISEASE-SYMPTOMATIC; 5.2.1 Vestibular Nystagmus; 5.2.1.1 Peripheral Vestibular Imbalance; 5.2.1.2 Central Vestibular Imbalance; 5.2.1.3 Central Vestibular Instability (Periodic Alternating); 5.2.2 Gaze-holding Deficiency Nystagmus; 5.2.2.1 Eccentric Gaze, Gaze-evoked, Rebound; 5.2.2.2 Gaze Instability (Run-away); 5.2.3 Vision-Loss Nystagmus; 5.2.3.1 Pre-chiasmal, Optic Chiasm, Post-chiasmal Vision Loss; 5.2.4 Other Pendular Nystagmus Associated with Diseases of Central Myelin; 5.2.4.1 Oculopalatal Tremor or Myoclonus; 5.2.4.2 Pendular Vergence Nystagmus Associated with Whipple’s Disease; 5.2.5 Convergence/Convergence Evoked Nystagmus; 5.2.6 Upbeat Nystagmus; 5.2.7 Downbeat Nystagmus; 5.2.8 Torsional Nystagmus; 5.2.9 See-Saw Nystagmus; 5.2.10 Lid Nystagmus; 5.3 SACCADIC INTRUSIONS/OSCILLATIONS; 5.3.1 Square Wave Jerks And Oscillations; 5.3.2 Square-Wave Pulses; 5.3.3 Staircase Saccadic Intrusions; 5.3.4 Macrosaccadic Oscillations; 5.3.5 Saccadic Pulses (Single And Double); 5.3.6 Convergence Retraction Nystagmus; 5.3.7 Dissociated Ocular Oscillations; 5.3.8 Dysmetric Saccades; 5.3.9 Ocular Flutter; 5.3.10 Flutter Dysmetria; 5.3.11 Opsoclonus; 5.3.11.1 Opsoclonus-Myoclonus; 5.3.12 Superior Oblique Myokymia; 5.3.13 Ocular bobbing; 5.3.13.1 Typical; 5.3.13.2 Monocular; 5.3.13.3 Atypical; 5.3.14 Psychogenic (Voluntary) Flutter; Chapter 6. Afferent Visual System - Clinical Examination Procedures; 6.1 SUBJECTIVE TESTING; 6.1.1 Teller Acuity Card Procedure; 6.1.2 Visual Acuity Testing (High Spatial Frequency Vision); 6.1.3 Stereo Testing; 6.1.4 Color-Vision Testing; 6.1.5 Contrast-Sensitivity Testing; 6.1.6 Gaze- and Time-Dependent Acuity Testing; 6.1.7 Visual Field Testing; 6.2 OBJECTIVE TESTING; 6.2.1 Visual Evoked Potentials; 6.2.2 Electroretinography; 6.2.3 Optical Coherence Tomography; 6.2.4 Fundus Photography; Chapter 7. Treatment; 7.1 MEDICAL; 7.1.1 Optical; 7.1.1.1 Version Prisms; 7.1.1.2 Vergence Prisms; 7.1.1.3 Contact Lenses; 7.1.1.4 Correction of Ammetropia/Anisometropia; 7.1.1.5 Intraocular Lenses; 7.1.1.6 Refractive Surgery; 7.1.2 Pharmacological; 7.1.2.1 Sedatives/Hypnotics; 7.1.2.2 Neuroleptics; 7.1.2.3 Psychoactive Medications; 7.1.2.4 Antiseizure Medications; 7.1.2.5 Botulinum; 7.1.2.6 Anticholinesterases; 7.2 EYE-MUSCLE SURGERY; 7.2.1 General Principles; 7.2.2 Classification; 7.2.3 Preoperative Evaluation; 7.2.3.1 Visual Acuity; 7.2.3.2 Ocular Motor and Standard Clinical Evaluations; 7.2.3.3 Strabismus; 7.2.3.4 Eye-Movement Recordings; 7.2.3.5 Head-Posture Measurements (Null Zones); 7.2.3.6 Laboratory and Special Tests; 7.2.4 Results; 7.2.4.1 Visual Acuity; 7.2.4.2 Strabismus; 7.2.4.3 Eye-Movement Recordings; 7.2.4.4 Head-Posture Measurements; 7.2.5 Complications; 7.3 OTHER; 7.3.1 Biofeedback; 7.3.2 Acupuncture; 7.3.3 Cutaneous Stimulation; 7.3.4 Gene Transfer Therapy; 7.3.5 Mind-Body Stress Reduction-Mindful Medication Techniques; 7.3.6 Occupational and Vision Therapy; 7.3.7 Educational Assistance; 7.4 ASSESSING THERAPEUTIC OUTCOMES (POST-THERAPY); 7.4.1 Direct Outcome Measures (NAFX, LFD, and Lt); 7.4.1.1 Post-Tenotomy & Reattachment; 7.4.1.2 Post-Convergence/Bimedial Rectus Recession; 7.4.1.3 Post-Four-Muscle Recession & Resection; or Two-Muscle Recession + Tenotomy & Reattachment; 7.4.1.4 Soft Contact Lenses; 7.4.1.5 Systemic Acetazolamide and Topical Brinzolamide; 7.4.2 Indirect/Clinical Outcome Measures; 7.4.2.1 Visual Acuity at Different Gaze Angles; 7.5 ESTIMATING THERAPEUTIC OUTCOMES (POST-THERAPY); 7.5.1 Direct Outcome Measures (NAFX, LFD, and Lt); 7.5.1.1 Tenotomy & Reattachment (INS without Afferent Visual Deficits); 7.5.1.2 Tenotomy & Reattachment (INS with Afferent Visual Deficits); 7.5.1.3 Prisms/Bimedial Rectus Recession; 7.5.1.4 Soft Contact Lenses; 7.5.2 Indirect/Clinical Outcome Measures; 7.5.2.1 Visual Acuity at Different Gaze Angles; Chapter 8. Summary and Conclusions; Epilogue; Appendices; Appendix A. Eye-Movement Recording Systems and Criteria; A.1 RECORDING METHODS; A.1.1 Contact Electrooculography; A.1.2 Infrared Reflection; A.1.3 Scleral Search Coil; A.1.4 High-Speed Video Oculography; A.2 RESEARCH CRITERIA; A.2.1 NAFX; A.2.1.1 Methodology; A.2.1.2 Estimating Visual Function Improvements; A.3 CLINICAL CRITERIA; A.3.1 Waveform Types; A.3.2 Null and Neutral Zones; A.3.3 PAN and APAN; A.3.4 Symmetry, Conjugacy, Vergence, and Monocular Evaluation; A.4 CALIBRATION TECHNIQUES; A.4.1 Adults and Children; A.4.1.1 Infantile Nystagmus; A.4.1.2 Fusion Maldevelopment Nystagmus; A.4.2 Infants; Appendix B. Clinical Examination; B.1 GENERAL CLINICAL EXAMINATION FORM; B.2 NYSTAGMUS EXAMINATION FORM; B.3 STRABISMUS EXAMINATION FORM; B.4 CLINICAL PEARLS; B.5 OPHTHALMOLOGICAL MYTHS AND FACTS; Appendix C. Illustrative Cases and Treatment; C.1 INFANTILE NYSTAGMUS SYNDROME; C.1.1 Gaze-Angle Null Only; C.1.1.1 Version Prisms; C.1.1.2 Soft Contact Lenses; C.1.1.3 Four-Muscle Resection, Recession, and Tenotomy & Reattachment; C.1.1.3.1. Fine Tuning with Prisms; C.1.1.3.2. Soft Contact Lenses; C.1.2 Convergence Null Only; C.1.2.1 Vergence Prisms with Negative Spheres; C.1.2.2 Soft Contact Lenses; C.1.2.3 Bimedial Recession; C.1.3 Both Gaze-Angle and Convergence Nulls; C.1.3.1 Convergence > Gaze-Angle; C.1.3.1.1 Composite Prisms and Negative Spheres; C.1.3.1.2 Base-out Prisms and Negative Spheres; C.1.3.1.3 Soft Contact Lenses; C.1.3.1.4 Bimedial Recession; C.1.3.2 Gaze-Angle > Convergence; C.1.3.2.1 Version Prisms; C.1.3.2.2 Soft Contact Lenses; C.1.3.2.3 Four-Muscle Resection, Recession and; Tenotomy & Reattachment; C.1.4 No Nulls; C.1.4.1 Soft Contact Lenses; C.1.4.2 Four-Muscle Tenotomy & Reattachment; C.1.4.2.1 Tenotomy & Reattachment with Augmented; Tendon Suture; C.1.4.2.2 Augmented Tendon Suture Procedure sans; Tenotomy & Reattachment; C.1.4.3 Faden; C.2 INFANTILE NYSTAGMUS PLUS STRABISMUS; C.2.1 Gaze-Angle Null Only; C.2.1.1 Four-Muscle Resection, Recession and Tenotomy & Reattachment; C.2.2 Vertical and Torsional Nulls; C.2.3 No Nulls; C.2.3.1 Four-Muscle Tenotomy & Reattachment and Strabismus; C.3 FUSION MALDEVELOPMENT NYSTAGMUS SYNDROME; C.3.1 Uniocular Fixation; C.3.2 Alternating Fixation; C.3.3 Alexander’s Law Threshold; C.4 NYSTAGMUS BLOCKAGE SYNDROME; C.4.1 Bimedial Recession (plus Tenotomy & Reattachment); C.4.2 Recession and Resection plus Tenotomy & Reattachment; C.4.3 Four-Muscle Tenotomy & Reattachment; Appendix D. Diagnosis and Treatment Flow Charts; D.1 WAVEFORM-BASED DIAGNOSES; D.2 THERAPEUTICALLY EXPLOITABLE WAVEFORM CHARACTERISTICS; D.3 CLINICALLY BASED DIAGNOSES AND LIMITATIONS; D.4 THERAPEUTICALLY EXPLOITABLE CLINICAL CHARACTERISTICS; D.5 ANALYSIS GRAPHS; Appendix E. Included Compact Disk and On-Line Access Videos; E.1 EYEBALLS 3D EYE-MOTION AND WAVEFORM VIDEOS; MV1 INS (PPfs) 1 cycle 1/20-speed illustrating foveation period; MV2 INS (Jef) 4 cycles 1/3-speed with phase plane; MV3 INS (PPfs) 3 cycles 12-speed illustrating well-developed foveation; MV4 INS (PPfs) 3 cycles 1/5-speed with phase plane; MV5 INS (PPfs) 12-speed 3-dimensional motion with subclinical SSN; MV6 INS 1/5-speed Subclinical SSN motion amplified; MV7 INS PPfs 12-speed from OMS model and patient; MV8 INS (Pfs) step responses OMS model; MV9 INS (PPfs) 12-speed pulse responses OMS model; MV10 INS (PPfs) 12-speed OMS model ramp and step-ramp responses; MV11 FMNS gaze-angle effect OMS model; MV12 FMNS 12-speed alternate cover test OMS model; MV13 FMNS adducting eye fixation OMS model; MV14 INS damping with rapid convergence; MV15 INS 12-speed pre-T&R; MV16 INS 12-speed post-T&R; MV17 INS 12-speed RPE65-deficient canine pre-gene therapy MV18 INS 12-speed RPE65-deficient canine pre-gene therapy scan path; MV19 INS 12-speed RPE65-deficient canine post-gene therapy MV20 INS 12-speed RPE65-deficient canine post-gene therapy scan path; MV21 Oscillopsia simulation; MV22 Uniocular APN pre- and post-therapy; MV23 INS (alternating J) OMS model; E.1.1 PowerPoint Files; E.1.1 E1_INS Dynamic VA; E.1.2 E1_INS Latency Poster; E.1.3 E1_ INS Latency; E.1.4 E1_ INS Model Poster; E.2 CANINE VIDEOS (PLUS OTHERS); CV1 Normal Brittany; CV2 Achiasmatic Belgian Sheepdog: pre-T&R; CV3 Achiasmatic Belgian Sheepdog: post-T&R; CV4 RPE65-deficient canine: pre-gene therapy behavior; CV5 RPE65-deficient canine: post-gene therapy behavior; CV6 RPE65-deficient canine: pre-gene therapy eye movements; CV7 RPE65-deficient canine: post-gene therapy eye movements; CV8 Cat with INS; CV9 Goat with SSN; E.3 PATIENT VIDEOS; PV1 Saccadic Initiation Failure; PV2 Brainstem Tumor: Tonic Gaze Deviation; PV3 Acquired Downbeat Nystagmus; PV4 Acquired Gaze-Evoked (Gaze-Holding Failure) Nystagmus; PV5 Acquired Unidirectional Gaze-Evoked (Gaze-Holding Failure) Nystagmus; PV6 Ocular Motor Neuromyotonia of Cranial Nerve III; PV7 Ocular Motor Neuromyotonia of Cranial Nerve VI; PV8 Infant with Opsoclonus (Ocular Flutter - Saccadomania); PV9 Acquired Saccadic Oscillations-1; PV10 Acquired Saccadic Oscillations-2; PV11Acquired Saccadic Oscillations-3; PV12 Acquired Nystagmus + Saccadic Oscillations; PV13 Acquired Upbeat Nystagmus with Wiernecke’s Encephalopathy; PV14 Acquired Vertical Pendular Nystagmus; PV15 Fusion Maldevelopment Nystagmus-1; PV16 Fusion Maldevelopment Nystagmus-2; PV17 Down Syndrome and Infantile Nystagmus; PV18 Achiasma + See-Saw Nystagmus + Infantile Nystagmus; PV19 Octogenarian with Infantile Nystagmus; PV20 Infantile Nystagmus: Aperiodically Changing Intensity (Not Direction); PV21 Infantile Nystagmus: Aperiodically Changing Direction (Not Intensity); PV22 Infantile Nystagmus: Unequal-1; PV23 Infantile Nystagmus: Unequal-2; PV24 Infantile Nystagmus: Unequal-3; PV25 Infantile Nystagmus: Jerk with Extended Foveation; PV26 Infantile + NOT Nystagmus: Dual Jerk; PV27 Infantile Nystagmus: Pre- and Post-Operative; PV28 Optic Nerve Dysplasia and Infantile Nystagmus: Multiplanar; PV29 Infantile Nystagmus: Jerk with Extended Foveation; PV30 Infantile Nystagmus: Unequal with a latent component; PV31 Albinism and Infantile Nystagmus; PV32 Optic Nerve Dysplasia and Infantile Nystagmus: Multiplanar; PV33 Albinism, Up-gaze Null, and Infantile Nystagmus: Equal; PV34 Retinal Dystrophy and Infantile Nystagmus: Multiplanar; PV35 Albinism and Infantile Nystagmus: Pre- and Post-Operative Horizontal Null; PV36 Albinism and Infantile Nystagmus: Multiplanar; PV37 Infantile Nystagmus: Periodic Alternating; PV38 Infantile Nystagmus: Asymmetric Aperiodic Alternating; PV39 Albinism and Infantile Nystagmus: Pre- and Post-Operative Vertical Null; PV40 Albinism, Up-gaze Null, and Infantile Nystagmus; PV41 Albinism and Infantile Nystagmus; PV42 Vertical Infantile Nystagmus-1; PV43 Retinal Dystrophy and Vertical Infantile Nystagmus-2; PV44 Spasmus Nutans Nystagmus-1; PV45 Spasmus Nutans Nystagmus-2; PV46 Voluntary Ocular Flutter; Appendix F. Included Compact Disk and On-Line Access; F.1 OMLAB REPORTS; F.1.1 #011105 Recording and Calibrating the Eye Movements of Nystagmus Subjects; F.1.2 #111005 Using the NAFX for Eye-Movement Fixation Data Analysis and Display; F.1.3 #111905 Nystagmus Therapies: Types, Sites, and Measures; F.1.4 #090506 Original Ocular Motor Analysis of the First Human with Achiasma:; Documentation of Work Done in 1994; F.1.5 #123007 The Benefits of Extraocular Muscle Surgery in INS; F.1.6 #030509 How Someone Sees the World and How to Clinically Assess; Therapeutic Improvements in Visual Function; F.2 PATIENT HANDOUTS; F.2.1 INS Information; F.2.2 INS Treatments; F.2.3 Tenotomy and Reattachment; F.2.4 INS and Acuity; F.2.5 INS Miscellaneous; F.3 PHYSICIAN/RESEARCH SCIENTIST WORKSHEETS; F.3.1 Recession and Resection Surgical Calculation; F.3.2 Estimating Improvement in Peak NAFX; F.3.3 Estimating Improvement in LFD; F.3.4 NAFX vs. Visual Acuity (Motor and Sensory Components); F.4 CLINICAL EXAMINATION FORMS; F.4.1 General Clinical Examination Form; F.4.2 Nystagmus Examination Form; F.4.3 Strabismus Examination Form; F.5 ANALYSIS SOFTWARE; F.5.1 OMtools; F.5.2 OMS Model GUI User Guide

Trade Policy 买家须知